A revolutionary new blood test could significantly advance our capacity for detecting cancer in its early stages. CancerSEEK, developed in John Hopkins University, could improve detection methods and consequently reduce mortality rates. Cancer is often a treatable condition. However, in many cases, it does not display symptoms for many years. As … [Read more...] about Blood test to detect early stage cancer
cancer
Biosimilars and the trastuzumab controversy
Swiss pharmaceutical company Roche is conducting consistent legal battles against smaller companies to dissuade them from entering the market of breast cancer medication reports The Wire. They claim that this has, in effect, granted Roche a monopoly over the biosimilars market, with an emphasis on the breast cancer medication trastuzumab. As a … [Read more...] about Biosimilars and the trastuzumab controversy
Access to advanced medicines and affordability: a look forward to 2016
We think that there will be unparalleled attention in 2016 on the issues of access to advanced medicines and on how to pay for them. Past controversies have largely focussed on access in low and middle income countries; this time Europe and North America will command at least as much attention. Ironically, the world’s richest and the poorest will … [Read more...] about Access to advanced medicines and affordability: a look forward to 2016
The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
